Hepatitis C virus infection.

MP Manns, M Buti, E Gane, Jean-Michel PAWLOTSKY, H Razavi, N Terrault, Z Younossi,

Net rev Dis Primers. 02/03/2017;3 : 17006 10.1038/nrdp.2017.6.

Hepatitis B Reactivation or Hepatitis C Exacerbation in Patients with Hematological Malignancies.

Isaac RUIZ, Jean-Michel PAWLOTSKY,

Ann Hepatol. 01/03/2017;16(2) : 179-181 10.5604/16652681.1231595

25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients.

A Belle, E Gizard, G Conroy, A Lopez, Magali BOUVIER-ALIAS, S Rouanet, L Peyrin-Biroulet, Jean-Michel PAWLOTSKY, JP Bronowicki,

United European Gastroenterol J. 01/02/2017;5(1) : 69-75 10.1177/2050640616640157. 07/07/2016

Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection.

JJ Feld, IM Jacobson, MS Sulkowski, F Poordad, F Tatsch, Jean-Michel PAWLOTSKY,

Liver Int. 01/01/2017;37(1) : 5-18 10.1111/liv.13212 29/09/2016

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features.

Julien CALDERARO, Benoit ROUSSEAU, Giuliana AMADDEO, M Mercey, C Charpy, CE Costentin, Alain LUCIANI, ES Zafrani, A Laurent, D Azoulay, Fouad LAFDIL, Jean-Michel PAWLOTSKY,

Hepatology 01/12/2016;64(6) : 2038-2046 10.1002/hep.28710. 09/08/2016

The end of the hepatitis C burden: Really?

Jean-Michel PAWLOTSKY,

Hepatology 01/11/2016;64(5) : 1404-1407 10.1002/hep.28758. 25/08/2016

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response.

G Cloherty, Stephane CHEVALIEZ, C Sarrazin, C Herman, V Holzmayer, G Dawson, B Maasoumy, J Vermehren, H Wedemeyer, JJ Feld, Jean-Michel PAWLOTSKY,

Sci Rep. 20/10/2016;6 : 35410 10.1038/srep35410.

Hepatitis C Drugs: Is Next Generation the Last Generation?

Jean-Michel PAWLOTSKY,

Gastroenterology 01/10/2016;151(4) : 587-590 10.1053/j.gastro.2016.08.043 30/08/2016

Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities.

Abdelhakim AHMED-BELKACEM, L Colliandre, Nazim AHNOU, Quentin NEVERS, M Gelin, Y Bessin, Rozenn BRILLET, O Cala, D Douguet, W Bourguet, I Krimm, Jean-Michel PAWLOTSKY, JF Guichou,

Nat Commun. 22/09/2016;7 : 12777 10.1038/ncomms12777.

Fragment-based discovery of a new family of non-peptidic small-molecule cyclophilin inhibitors with potent antiviral activities.

L Colliandre, Nazim AHNOU, Quentin NEVERS, M Gelin, Y Bessin, Rozenn BRILLET, O Cala, D Douguet, W Bourguet, I Krimm, Jean-Michel PAWLOTSKY, JF Guichou, Abdelhakim AHMED-BELKACEM,

Nat Commun. 22/09/2016;7 : 12777 10.1038/ncomms12777.